Previous research showed that cancer patients with diabetes may have increased tumor cell proliferation and metastatic capacity as a consequence of the high insulin or increased free insulin-like growth factor (IGF-1) levels in hyperinsulinemic states [29]. Here, INS is linked to diabetes mellitus.